Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

Asta Theodorsdottir, Birgit Debrabant, Melinda Magyari, Matthias Kant, Peter V. Rasmussen, Carl Fredrik Malmberg, Iver A. Norberg, Victoria Hansen, Danny Bech, Mathias F. Schmidt, Karen Schreiber, Jette L. Frederiksen, Finn Sellebjerg, Zsolt Illes*

*Corresponding author

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalMultiple Sclerosis Journal
ISSN1352-4585
DOIs
Publication statusE-pub ahead of print - 29 Mar 2021

Keywords

  • adverse events
  • Alemtuzumab
  • CARE-MS
  • multiple sclerosis
  • observational study
  • real-world efficacy
  • registry

Fingerprint

Dive into the research topics of 'Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry'. Together they form a unique fingerprint.

Cite this